Cargando…
Oncolytic Viruses and Immune Checkpoint Inhibitors: The “Hot” New Power Couple
SIMPLE SUMMARY: Oncolytic viruses (OV) are engineered viruses designed to replicate selectively within tumour cells. They hold great promise as novel cancer therapeutics, but their performance clinically has, to date, failed to match expectations. One area of increasing interest in OV is the ability...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453115/ https://www.ncbi.nlm.nih.gov/pubmed/37627206 http://dx.doi.org/10.3390/cancers15164178 |